MPP+ Injection into Rat Substantia Nigra Causes Secondary Glial Activation but Not Cell Death in the Ipsilateral Striatum

MPP+ Injection into Rat Substantia Nigra Causes Secondary Glial Activation but Not Cell Death in the Ipsilateral Striatum

Injection of MPP+ into the substantia nigra causes extensive necrosis and anterograde degeneration of pars compacta dopaminergic neurons. We studied secondary effects in the ipsilateral striatum by examining dopaminergic terminals, signs of neuronal damage, and glial reactivity at 1, 2, 3, and 7 day...

Full description

Bibliographic Details
Main Authors:	Anna M. Canudas, Bibiana Friguls, Anna M. Planas, Cecı´lia Gabriel, Elena Escubedo, Jordi Camarasa, Antoni Camins, Mercè Pallàs
Format:	Article
Language:	English
Published:	Elsevier 2000-08-01
Series:	Neurobiology of Disease
Subjects:	reactive glia [3H]PK 11195 binding immunohistochemistry rat
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996100903085

Similar Items

Paeoniflorin elicits the anti-proliferative effects on glioma cell via targeting translocator protein 18 KDa
by: Zhuo-wei Gao, et al.
Published: (2021-01-01)

In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
by: Carlos Eduardo Sampaio Guedes, et al.
Published: (2018-02-01)

Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum
by: Jae K. Ryu, et al.
Published: (2005-11-01)

Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy
by: Marcelo Barreto Spillere da Silva, et al.
Published: (2004-01-01)

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
by: Alexander Gerhard, et al.
Published: (2006-02-01)

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
by: Paul Edison, et al.
Published: (2008-12-01)

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
by: Peter Parbo, et al.
Published: (2020-01-01)

The TSPO-specific Ligand PK11195 Protects Against LPS-Induced Cognitive Dysfunction by Inhibiting Cellular Autophagy
by: Nannan Lan, et al.
Published: (2021-01-01)

Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study
by: Paolo Giannetti, et al.
Published: (2014-05-01)

TSPO Ligands PK11195 and Midazolam Reduce NLRP3 Inflammasome Activation and Proinflammatory Cytokine Release in BV-2 Cells
by: Hao Feng, et al.
Published: (2020-12-01)

Evaluation of age-related changes in translocator protein (TSPO) in human brain using <sup>11</sup>C-[R]-PK11195 PET
by: Kumar Ajay, et al.
Published: (2012-10-01)

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: Implications for PET imaging of neuroinflammation in lentiviral encephalitis
by: Sriram Venneti, et al.
Published: (2008-02-01)

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
by: M.R Turner, et al.
Published: (2004-04-01)

The Interplay of Cholesterol and Ligand Binding in <i>h</i>TSPO from Classical Molecular Dynamics Simulations
by: Hien T. T. Lai, et al.
Published: (2021-02-01)

MODULATION OF THE ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR FOLLOWING EXPERIMENTAL RAT BRAIN INJURY IMPROVES CELLULAR AND BEHAVIORAL OUTCOMES
by: Woodcock, Thomas Matt
Published: (2010)

Avaliação dos efeitos dos ligantes de TSPO (translocator protein 18 KDa) na ativação dos neutrófilos
by: Léonard De Vinci Kanda Kupa
Published: (2015)

Avaliação dos efeitos dos ligantes de TSPO (translocator protein 18 KDa) na ativação dos neutrófilos
by: Kupa, Léonard De Vinci Kanda
Published: (2015)

PK11195 Protects From Cell Death Only When Applied During Reperfusion: Succinate-Mediated Mechanism of Action
by: Lea K. Seidlmayer, et al.
Published: (2021-05-01)

Imagem PET de processos relacionados à esclerose múltipla: estudo pré-clínico
by: Carvalho, Robert Honorato Fraga
Published: (2019)

11C-PK11195 plasma metabolization has the same rate in multiple sclerosis patients and healthy controls: a cross-sectional study
by: Aline Morais de Souza, et al.
Published: (2021-01-01)

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function
by: Pontus Plavén-Sigray, et al.
Published: (2018-11-01)

Enhanced training protects memory against amnesia produced by concurrent inactivation of amygdala and striatum, amygdala and substantia nigra, or striatum and substantia nigra
by: Rigoberto eSalado-Castillo, et al.
Published: (2011-12-01)

Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients
by: Athanasios Metaxas, et al.
Published: (2019-12-01)

MPP+Induced Substantia Nigra Degeneration Is Attenuated in nNOS Knockout Mice
by: Russell T. Matthews, et al.
Published: (1997-01-01)

Striatal Infarction in the Rat Causes a Transient Reduction of Tyrosine Hydroxylase Immunoreactivity in the Ipsilateral Substantia Nigra
by: Marc A. Soriano, et al.
Published: (1997-01-01)

The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease
by: Giacomo Tondo, et al.
Published: (2020-04-01)

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
by: Renee M. Miller, et al.
Published: (2006-02-01)

Striatal Infarction Elicits Secondary Extrafocal MRI Changes in Ipsilateral Substantia Nigra.
by: Benjamin Winter, et al.
Published: (2015-01-01)

Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder
by: Morten Gersel Stokholm, et al.
Published: (2018-07-01)

11C Molecular Imaging in Focal Epilepsy
by: Danfors, Torsten
Published: (2012)

Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model
by: Yi Lu, et al.
Published: (2018-02-01)

The Differentially Expressed Circular RNAs in the Substantia Nigra and Corpus Striatum of Nrf2-Knockout Mice
by: Jun-Hui Yang, et al.
Published: (2018-10-01)

The microcircuitry of the substantia nigra
by: Boyes, Justin
Published: (2004)

Cell-Mediated Delivery of Brain-Derived Neurotrophic Factor Enhances Dopamine Levels in an Mpp+ Rat Model of Substantia Nigra Degeneration
by: Wendy R. Galpern, et al.
Published: (1996-03-01)

Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids
by: Henriqueta Dias Cardoso, et al.
Published: (2012-08-01)

Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversity
by: Nuzhat N. Kabir, et al.
Published: (2011-01-01)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
by: Anna Faynveitz, et al.
Published: (2019-09-01)

Activation of ERK and Akt Signaling in Focal Cerebral Ischemia: Modulation by TGF-α and Involvement of NMDA Receptor
by: Bibiana Friguls, et al.
Published: (2002-12-01)

Metabolic Regulation of Glial Phenotypes: Implications in Neuron–Glia Interactions and Neurological Disorders
by: Ruqayya Afridi, et al.
Published: (2020-02-01)

Subthalamic control of dopamine release in the substantia nigra
by: Barstow, Karen L.
Published: (2019)